Abstract
Previous studies have shown that Qing Kai Ling, a traditional Chinese medicine, was able to effectively prevent the inflammation from cerebral ischemia (Chen et al., 2002). The cholalic acid and hyodeoxycholalic acid (cholalic acid mixture) was major active components in Qing Kai Ling. To study the effects of cholalic acid mixture on the damage cascade of cerebral ischemia, rat model of focal cerebral ischemia was established by permanent occlusion of left middle cerebral artery. We found that the administration of cholalic acid mixture could reduce the ischemic infarct size after 24 h of ischemia, and cholalic acid mixture could be detected in cerebrospinal fluid after 2h of administration. We also found that the concentrations of tumor necrosis factor-alpha and interlukin-1beta in rat brain were significantly lower when compared to the untreated animals after 12 h and 24 h of ischemia. The concentrations of von Willebrand factor and neuron specific enolase in the plasma were remarkably decreased in cholalic acid mixture treated animals than in the untreated ones after 12h of ischemia. Our results suggested that cholalic acid mixture is able to decrease the expression of inflammation factors including tumor necrosis factor-alpha and interlukin-1beta after focal cerebral ischemia.
Similar content being viewed by others
Abbreviations
- (TNF-α):
-
tumor necrosis factor-alpha
- (IL-1β):
-
interlukin-1 beta
- (NMDA):
-
N-methyl-D-aspartate
- (ICAM-1):
-
intercellular adhensive molecular-1
- (vWF):
-
von Willebrand factor
- (NSE):
-
neuron-specific enolase
- (QKL):
-
Qing Kai Ling
- (MCAO):
-
middle cerebral artery occlusion
- (ECA):
-
external carotid artery
- (ICA):
-
internal carotid artery
- (RIA):
-
Radioimmunoassay
- (ip.):
-
intra-peritoneally
- (BBB):
-
brain blood barrier
References
Barber, P. A., Auer, R. N., Buchan, A. M., and Sutherland, G. R., Understanding and managing ischemic stroke. Can. J. Physiol. Pharmacol., 79, 283–296 (2001).
Barone, F. C., Clark, R. K., Price, W. J., White, R. F., Feuerstein, G. Z., Storer, B. L., and Ohlstein, E. H., Neuron-specific enolase increases in cerebral and systemic circulation following focal ischemia. Brain Res., 623, 77–82 (1993).
Barone, F. C., Arvin, B., White, R. F., Miller, A., Webb, C. L., Willette, R. N., Lysko, P. G., and Feuerstein, G. Z., Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke, 28, 1233–1244 (1997).
Botker, H. E. and Ingerslev, J., Plasma concentrations of von Willebrand factor in patients with anginapectoris secondary to coronary atherosclerosis or cardiac syndrome. Thromb. Res., 97, 519–523 (2000).
Chen, X., Howard, O. M., Yang, X., Wang, L., Oppenheim, J. J., and Krakauer, T., Effects of Shuanghuanglian and Qingkailing, two multi-components of traditional Chinese medicinal preparations, on human leukocyte function. Life Sci., 70, 2897–2913 (2002).
Clemens, J. A., Stephenson, D. T., Dixon, E. P., Smalstig, E. B., Mincy, R. E., Rash, K. S., and Little, S. P., Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Brain Res. Mol. Brain Res., 48, 187–196 (1997).
Dai, K., Gao, W., and Ruan, C., The Sma I polymorphism in the von Willebrand factor gene associated with acute ischemic stroke. Thromb. Res., 104, 389–395 (2001).
Emsley, H. C. and Tyrrell, P. J., Inflammation and infection in clinical stroke. J. Cereb. Blood Flow Metab., 22, 1399–1419 (2002).
Gong, C., Qin, Z., Betz, A. L., Liu, X. H., and Yang, G. Y., Cellular localization of tumor necrosis factor alpha following focal cerebral ischemia in mice. Brain Res., 801, 1–8 (1998).
Hatfield, R. H. and McKernan, R. M., CSF neuron-specific enolase as a quantitative marker of neuronal damage in a rat stroke model. Brain Res., 577, 249–252 (1992).
Hua, Q., Zhu, X-L., Li, P-T., Tang, H-L., Cai, D-Y., Xu, Y., Jia, X., Chen, J., and Shen, Y., Refined qing kai ling, traditional chinese medicinal preparation, reduces ischemic stroke-induced infarct size and neurological deficits and increases expression of endothelial nitric oxide synthase. Biol. Pharm. Bull., 31, 633–637 (2008).
Jean, W. C., Spellman, S. R., Nussbaum, E. S., and Low, W. C., Reperfusion injury after focal cerebral ischemia: The role of inflammation and the therapeutic horizon. Neurosurgery, 43, 1382–1396 (1998).
Jing, Y., The effect of QingKaiLing on the treatment of stroke. J. Beijing Univ. Chin. Med., 4, 77–79 (2001).
Kim, Y. O., Leem, K., Park, J., Lee, P., Ahn, D. K., Lee, B. C., Park, H. K., Suk, K., Kim, S. Y., and Kim, H., Cytoprotective effect of Scutellariascutellarin baicalensis in CA1 hippocampal neurons of rats after global cerebral ischemia. J. Ethnopharmacol., 77, 183–188 (2001).
Kumari, M., Marmot, M., and Brunner, E., Social determinants of von willebrand factor: the Whitehall II study. Arterioscler. Thromb. Vasc. Biol., 20, 1842–1847 (2000).
Lavine, S. D., Hofman, F. M., and Zlokovic, B. V., Circulating antibody against tumor necrosis factor-alpha protects rat brain from reperfusin injury. J. Cereb. Blood Flow Metab., 18, 52–58 (1998).
Li, C.-Y., Pan, Y.-S., Jia, X., Li, K.-L., Liu, C.-M., Wang, X., and Li, P.-T., Effect of Huang qin (dried root of scutell-ariabaicalensis) and Zhizi (dried fruit of gardenia jasminoides) used in combination on ischemic cascade reaction in the rat model of focal cerebral ischemia and reperfusion. J. Beijing Univ. Chin. Med., 25, 31–33 (2002).
Longa, E. Z., Weinstein, P. R., Carlson, S., and Cummins, R., Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20, 84–91 (1989).
Ma, Q. C., Ma, J. S., and Sun, N. L., Clinical observation on effect of intervention therapy with anticoagulant in treating patients of hypertension complicated with acute ischemic cerebrovascular disease. Chin. J. Integ. Trad. Western Med., 21, 257–259 (2001).
Nawashiro, H., Tasaki, K., Ruetzler, C. A., and Hallenbeck, J. M., TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab., 17, 483–490 (1997a).
Nawashiro, H., Martin, D., and Hallenbeck, J. M., Neuroprotective effects of TNF binding protein in focal cerebral ischemia. Brain Res., 778, 265–271 (1997b).
Ran, X., Liang, Q., Luo, G., Liu, Q., Pan, Y., Wang, B., and Pang, C. Simultaneous determination of geniposide, baicalin, cholic acid and hyodeoxycholic acid in rat serum for the pharmacokinetic investigations by high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci., 842, 22–27 (2006).
Schaarschmidt, H., Prange, H. W., and Reiber, H., Neuronspecific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke, 25, 558–565 (1994).
Tang, Y-H., Zhang, S-P., Liang, Y., and Deng, C-Q., Effects of Panax notoginseng saponins on mRNA expressions of interleukin-1β, its correlative factors and cysteinyl-aspartate specific protease after cerebral ischemia-reperfusion in rats. J. Chin. Integ. Med., 5, 328–332 (2007).
Tartaglia, L. A., Ayres, T. M., Wong, G. H., and Goeddel, D. V., A novel domain within the 55 kd TNF receptor signals cell death. Cell, 74, 845–853 (1993).
Tasaki, K., Ruetzler, C. A., Ohtsuki, T., Martin, D., Nawashiro, H., and Hallenbeck, J. M., Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res., 748, 267–270 (1997).
Uno, H., Matsuyama, T., Akita, H., Nishimura, H., and Sugita, M., Induction of tumor necrosis factor-alpha in the mouse hippocampus following transient forebrain ischemia. J. Cereb. Blood Flow Metab., 17, 491–499 (1997).
Wang, C. X. and Shuaib, A., Involvement of inflammatory cytokines in central nervous system injury. Prog. Neurobiol., 67, 161–172 (2002).
Ware, C. F., VanArsdale, S., and VanArsdale, T. L., Apoptosis mediated by the TNF-related cytokine and receptor families. J. Cell Biochem., 60, 47–55 (1996).
Williams, A. J., Berti, R., Dave, J. R., Elliot, P. J., Adams, J., and Tortella, F. C., Delayed treatment of ischemia/reperfusion brain injury: extended therapeutic window with the proteosome inhibitor MLN519. Stroke, 35, 1186–1191 (2004).
Yang, G.-Y., Liu, X.-H., Kadoya, C., Zhao, Y.-J., Mao, Y., Davidson, B. L., and Betz, A. L., Attenuation of ischemic inflammatory response in mouse brain using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist. J. Cereb. Blood Flow Metab., 18, 840–847 (1998a).
Yang, G.-Y., Gong, C., Qin, Z., Ye, W., Mao, Y., and Bertz A. L. Inhibition of TNF-alpha attenuates infarct volume and ICAM-1 expression in ischemic mouse brain. Neuroreport, 9, 2131–2134 (1998b).
Zhang, F. and Li, X-H., The influence of total saponion of panax notoginseng on the expression of TNF-α in rats with focal cerebral ischemia and reperfusion. Chin. J. Integ. Med. Cardio/Cerebrovas. Dis., 5, 597–599 (2007).
Zhang, Y., Zhang, X., Park, T. S., and Gidday, J. M., Cerebral endothelial cell apoptosis after ischemia-reperfusion: role of PARP activation and AIF translocation. J. Cereb. Blood Flow Metab., 25, 868–877 (2005).
Author information
Authors and Affiliations
Corresponding author
Additional information
These two authors contribute equally to the paper.
Rights and permissions
About this article
Cite this article
Hua, Q., Zhu, Xl., Li, Pt. et al. The inhibitory effects of cholalic acid and hyodeoxycholalic acid on the expression of TNFα and IL-1β after cerebral ischemia in rats. Arch. Pharm. Res. 32, 65–73 (2009). https://doi.org/10.1007/s12272-009-1119-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-009-1119-z